A germline mutation in PBRM1 predisposes to renal cell carcinoma

被引:35
|
作者
Benusiglio, Patrick R. [1 ,2 ]
Couve, Sophie [3 ,4 ,5 ]
Gilbert-Dussardier, Brigitte [1 ,6 ]
Deveaux, Sophie [1 ]
Le Jeune, Helene [3 ,4 ,5 ]
Da Costa, Melanie [3 ,4 ,5 ]
Fromont, Gaelle [7 ]
Memeteau, Francoise [8 ]
Yacoub, Mokrane [9 ]
Coupier, Isabelle [1 ,10 ,11 ]
Leroux, Dominique [1 ,12 ]
Mejean, Arnaud [1 ,13 ,14 ]
Escudier, Bernard [15 ]
Giraud, Sophie [1 ,16 ]
Gimenez-Roqueplo, Anne-Paule [17 ]
Blondel, Christophe [18 ]
Frouin, Eric [19 ]
Teh, Bin T. [20 ,21 ,22 ]
Ferlicot, Sophie [1 ,23 ]
Bressac-de Paillerets, Brigitte [18 ]
Richard, Stephane [1 ,3 ,4 ,5 ]
Gad, Sophie [3 ,4 ,5 ]
机构
[1] Hop Bicetre, Ctr Expert Natl Canc Rares PREDIR AP HP INCa, Le Kremlin Bicetre, France
[2] Consultat Oncogenet, Dept Med Oncol, Villejuif, France
[3] Ecole Prat Hautes Etud, Paris, France
[4] INSERM, U753, Lab Genet Oncol EPHE, F-94800 Villejuif, France
[5] Univ Paris 11, Fac Med, Le Kremlin Bicetre, France
[6] CHU Poitiers, Serv Genet Med, Poitiers, France
[7] CHRU Tours, INSERM UMR1069, Serv Anat & Cytol Pathol, Tours, France
[8] Ctr Hosp Niort, Dept Anat & Cytol Pathol, Niort, France
[9] CHU Pellegrin Bordeaux, Serv Pathol, Bordeaux, France
[10] CRLC Val Aurelle, Unite Oncogenet, Montpellier, France
[11] CHU Montpellier, Unite Oncogenet, Serv Genet Med, Montpellier, France
[12] CHU Grenoble Site Nord, Inst Biol & Pathol, Dept Hematol Oncogenet & Immunol, La Tronche, France
[13] Hop Europeen Georges Pompidou, AP HP, Serv Urol, Paris, France
[14] Univ Paris 05, Paris, France
[15] INSERM, U753, Dept Med Oncol, F-94800 Villejuif, France
[16] Hop Edouard Herriot, Genet Mol & Clin, Lyon, France
[17] Hop Europeen Georges Pompidou, AP HP, Dept Genet Mol, Paris, France
[18] Serv Genet, Dept Biopathol, Villejuif, France
[19] CHU Poitiers, Serv Anat & Cytol Pathol, Poitiers, France
[20] Natl Canc Ctr, Div Med Sci, NCCS VARI Translat Res Lab, Singapore, Singapore
[21] Duke NUS Grad Med Sch, Program Canc & Stem Cell Biol, Singapore, Singapore
[22] Natl Univ Singapore, Ctr Life Sci, Canc Sci Inst Singapore, Singapore 117548, Singapore
[23] Hop Bicetre, AP HP, Serv Anat Pathol, Le Kremlin Bicetre, France
关键词
VON-HIPPEL-LINDAU; BAP1; MELANOMA; DISEASE; CANCER;
D O I
10.1136/jmedgenet-2014-102912
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background Many cases of familial renal cell carcinoma (RCC) remain unexplained by mutations in the known predisposing genes or shared environmental factors. There are therefore additional, still unidentified genes involved in familial RCC. PBRM1 is a tumour suppressor gene and somatic mutations are found in 30-45% of sporadic clear cell (cc) RCC. Methods We selected 35 unrelated patients with unexplained personal history of ccRCC and at least one affected first-degree relative, and sequenced the PBRM1 gene. Results A germline frameshift mutation (c.3998_4005del [p.Asp1333Glyfs]) was found in one patient. The patient's mother, his sister and one niece also had ccRCC. The mutation co-segregated with the disease as the three affected relatives were carriers, while an unaffected sister was not, according with autosomal-dominant transmission. Somatic studies supported these findings, as we observed both loss of heterozygosity for the mutation and loss of protein expression in renal tumours. Conclusions We show for the first time that an inherited mutation in PBRM1 predisposes to RCC. International studies are necessary to estimate the contribution of PBRM1 to RCC susceptibility, estimate penetrance and then integrate the gene into routine clinical practice.
引用
收藏
页码:426 / 430
页数:5
相关论文
共 50 条
  • [1] Mutational Analysis of PBRM1 and Significance of PBRM1 Mutation in Anti-PD-1 Immunotherapy of Clear Cell Renal Cell Carcinoma
    Aili, Abudureyimujiang
    Wen, Jie
    Xue, Lixiang
    Wang, Junjie
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [2] Significance of PBRM1 mutation in disease progress and drug selection in clear cell renal cell carcinoma
    He, Donghua
    Ma, Tianyan
    Yi, Ni
    Zhang, Sijie
    Ding, Guanxiong
    [J]. BIOTECHNOLOGY AND GENETIC ENGINEERING REVIEWS, 2023, 40 (04) : 3901 - 3915
  • [3] PBRM1 and BAP1 expression in renal cell carcinoma
    Kuthi, L.
    Fallmann, E.
    Jenei, A.
    Posfai, B.
    Maraz, A.
    [J]. VIRCHOWS ARCHIV, 2018, 473 : S44 - S44
  • [4] Loss of PBRM1 expression is associated with renal cell carcinoma progression
    Pawlowski, Rafal
    Muehl, Sarah M.
    Sulser, Tullio
    Krek, Wilhelm
    Moch, Holger
    Schraml, Peter
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2013, 132 (02) : E11 - E17
  • [5] Prognostic and clinicopathological value of PBRM1 expression in renal cell carcinoma
    Wang, Zhun
    Peng, Shuanghe
    Guo, Linpei
    Xie, Hui
    Wang, Aixiang
    Shang, Zhiqun
    Niu, Yuanjien
    [J]. CLINICA CHIMICA ACTA, 2018, 486 : 9 - 17
  • [6] Prognostic and Predictive Value of PBRM1 in Clear Cell Renal Cell Carcinoma
    Carril-Ajuria, Lucia
    Santos, Maria
    Maria Roldan-Romero, Juan
    Rodriguez-Antona, Cristina
    de Velasco, Guillermo
    [J]. CANCERS, 2020, 12 (01)
  • [7] The Suggested Importance of PBRM1 Mutation in Predicting Postoperative Recurrence of Localized Clear Cell Renal Cell Carcinoma
    Goldberg, Hanan
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (04) : 1889 - 1891
  • [8] The Suggested Importance of PBRM1 Mutation in Predicting Postoperative Recurrence of Localized Clear Cell Renal Cell Carcinoma
    Hanan Goldberg
    [J]. Annals of Surgical Oncology, 2021, 28 : 1889 - 1891
  • [9] PBRM1 and BAP1 as Novel Targets for Renal Cell Carcinoma
    Brugarolas, James
    [J]. CANCER JOURNAL, 2013, 19 (04): : 324 - 332
  • [10] The Impact of PBRM1 Expression as a Prognostic and Predictive Marker in Metastatic Renal Cell Carcinoma
    Kim, Ji-Yeon
    Lee, Se-Hoon
    Moon, Kyung Chul
    Kwak, Cheol
    Kim, Hyeon Hoe
    Keam, Bhumsuk
    Kim, Tae Min
    Heo, Dae Seog
    [J]. JOURNAL OF UROLOGY, 2015, 194 (04): : 1112 - 1119